Travere Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Travere Therapeutics's estimated annual revenue is currently $89.9M per year.
- Travere Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Travere Therapeutics has 580 Employees.
- Travere Therapeutics grew their employee count by -10% last year.
Travere Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Sr. VP, Regulatory Affairs and Quality | Reveal Email/Phone |
3 | Chief IP Counsel - Contract | Reveal Email/Phone |
4 | VP, Research and Nonclinical Development | Reveal Email/Phone |
5 | VP Pharmacovigilance & Renal Clinical Development | Reveal Email/Phone |
6 | VP, Information Technology | Reveal Email/Phone |
7 | VP, Head Corporate Communications | Reveal Email/Phone |
8 | SVP, General Counsel & Secretary | Reveal Email/Phone |
9 | VP Regulatory Affairs | Reveal Email/Phone |
10 | VP, Associate General Counsel | Reveal Email/Phone |
Travere Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Travere Therapeutics?
At Travere Therapeutics, our mission is to identify, develop and deliver life-changing therapies to people living with rare disease. #InRareForLife
keywords:N/AN/A
Total Funding
580
Number of Employees
$89.9M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Travere Therapeutics News
2022-04-20 - Travere Therapeutics, Inc. (NASDAQ:TVTX) Expected to Earn ...
Travere Therapeutics, Inc. (NASDAQ:TVTX Get Rating) Investment analysts at Jefferies Financial Group issued their Q2 2022 earnings per...
2022-04-19 - Is Travere Therapeutics Inc (TVTX) Stock a Smart Value Tuesday?
Travere Therapeutics Inc gets a 82 rank in the Healthcare sector. Healthcare is number 6 out of 11 sectors. Overall Score - 72. TVTX has an...
2022-04-17 - Where Does Travere Therapeutics Inc (TVTX) Stock Fall in the Biotechnology
Field After It Is Down -4.09% This Week?
The 61 rating InvestorsObserver gives to Travere Therapeutics Inc (TVTX) stock puts it near the top of the Biotechnology industry.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $200.4M | 583 | 5% | N/A |
#2 | $131.2M | 583 | N/A | N/A |
#3 | $153.6M | 585 | 8% | N/A |
#4 | $147.3M | 587 | -20% | N/A |
#5 | $187.5M | 588 | 27% | N/A |